Literature DB >> 2885846

Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.

D Y Mochizuki, J R Eisenman, P J Conlon, A D Larsen, R J Tushinski.   

Abstract

A murine in vitro assay was developed to measure potentiation of a proliferative response to suboptimal concentrations of the hematopoietic regulatory molecule granulocyte/macrophage colony-stimulating factor by an immature bone marrow population. The assay, designated the 5-fluorouracil bone marrow proliferation assay, was used to characterize potentiating activity in serum-free culture supernatants of the human tumor cell line HBT 5637. Molecular and biochemical analyses indicated that the HBT 5637-derived potentiating activity could be attributed to interleukin 1 alpha. Serologic analysis using a monoclonal antibody against purified recombinant interleukin 1 alpha proved conclusively that the potentiating activity in HBT 5637 serum-free supernatants is due to interleukin 1 alpha. From these data, the activity of interleukin 1 alpha seems to be the same synergistic activity formerly ascribed to hemopoietin 1.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2885846      PMCID： PMC298836          DOI： 10.1073/pnas.84.15.5267

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  27 in total

1.  Granulocyte colony stimulating factor.

Authors:  N A Nicola
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

2.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.

Authors:  L M Souza; T C Boone; J Gabrilove; P H Lai; K M Zsebo; D C Murdock; V R Chazin; J Bruszewski; H Lu; K K Chen; J Barendt; E Platzer; M A S Moore; R Mertelsmann; K Welte
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

Review 3.  Interleukin 1: an immunological perspective.

Authors:  S K Durum; J A Schmidt; J J Oppenheim
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.

Authors:  C J March; B Mosley; A Larsen; D P Cerretti; G Braedt; V Price; S Gillis; C S Henney; S R Kronheim; K Grabstein
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

5.  Synergism between hemopoietic growth factors (HGFs) detected by their effects on cells bearing receptors for a lineage specific HGF: assay of hemopoietin-1.

Authors:  S H Bartelmez; E R Stanley
Journal:  J Cell Physiol       Date:  1985-03       Impact factor: 6.384

6.  Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor.

Authors:  L S Park; D Friend; S Gillis; D L Urdal
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

7.  Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor.

Authors:  M A Cantrell; D Anderson; D P Cerretti; V Price; K McKereghan; R J Tushinski; D Y Mochizuki; A Larsen; K Grabstein; S Gillis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin.

Authors:  C A Sieff; S G Emerson; R E Donahue; D G Nathan; E A Wang; G G Wong; S C Clark
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

9.  Induction of interleukin 2 responsiveness in thymocytes by synergistic action of interleukin 1 and interleukin 2.

Authors:  D N Männel; S B Mizel; T Diamantstein; W Falk
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

10.  Generation of anti-peptide monoclonal antibodies which recognize mature CSF-2 alpha (IL 3) protein.

Authors:  P J Conlon; K H Luk; L S Park; C J March; T P Hopp; D L Urdal
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422
View more
  39 in total

Review 1.  Regulation of hemopoietic cell development by interleukins 4, 5 and 6.

Authors:  D Rennick; S Hudak; G Yang; J Jackson
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

3.  Comparative analysis of the influences of IL-1, IL-3 and GM-CSF on the commitment of granulocyte-macrophage progenitors in vitro.

Authors:  J Maciejewski; H Weber; K Neuhaus; M Wächter; E Elstner; F R Seiler; H D Volk
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

4.  Two high-affinity interleukin 1 receptors represent separate gene products.

Authors:  R Chizzonite; T Truitt; P L Kilian; A S Stern; P Nunes; K P Parker; K L Kaffka; A O Chua; D K Lugg; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.

Authors:  J Brandt; N Baird; L Lu; E Srour; R Hoffman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Survival of hemopoietic progenitors in the G0 period of the cell cycle does not require early hemopoietic regulators.

Authors:  A G Leary; Y Hirai; T Kishimoto; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1.

Authors:  B M Curtis; B Gallis; R W Overell; C J McMahan; P DeRoos; R Ireland; J Eisenman; S K Dower; J E Sims
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Expression of genes for interleukin-1 alpha and tumour necrosis factor-alpha in newborn mice.

Authors:  M Lipoldová; V Holán
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

9.  Elevated levels of GM-CSF and IL-1 in the serum, peritoneal and pleural cavities of GM-CSF transgenic mice.

Authors:  A J Gearing; D Metcalf; J G Moore; N A Nicola
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

10.  Preventive effects of interleukin 1 beta for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies.

Authors:  S Tanaka; S Tabuchi; K Watanabe; H Takigawa; K Akatsuka; H Numata; Y Hokama; T Hori
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.